Abstract:Background Osteoporosis is a degenerative disease characterized by reduced bone mass, with low peak bone mass being the predominant manifestation during development and having an intrauterine origin. Pregnant women at risk of preterm delivery are commonly treated with dexamethasone to promote fetal lung development. However, pregnant dexamethasone exposure (PDE) can lead to reduced peak bone mass and susceptibility to osteoporosis in offspring. In this study, we aimed to investigate the mechanism of PDE-induced low peak bone mass in female offspring from the perspective of altered osteoclast developmental programming. Methods 0.2 mg/kg.d dexamethasone was injected subcutaneously into rats on gestation days (GDs) 9-20. Some pregnant rats were killed at GD20 to remove fetal rat long bones, the rest were delivered naturally, and some adult offspring rats were given ice water swimming stimulation for two weeks. Results The results showed that the fetal rat osteoclast development was inhibited in the PDE group compared with the control group. In contrast, the adult rat osteoclast function was hyperactivation with reduced peak bone mass. We further found that the promoter region methylation levels of lysyl oxidase (LOX) were decreased, the expression was increased, and the production of reactive oxygen species (ROS) was raised in PDE offspring rat long bone before and after birth. Combined in vivo and in vitro experiments, we confirmed that intrauterine dexamethasone promoted the expression and binding of the glucocorticoid receptor (GR) and estrogen receptor beta(ER beta) in osteoclasts and mediated the decrease of LOX methylation level and increase of expression through upregulation of 10-11 translocator protein 3 ( Tet3). Conclusions Taken together, we confirm that dexamethasone causes osteoclast LOX hypomethylation and high expression through the GR/ER beta/Tet3 pathway, leading to elevated ROS production and that this intrauterine epigenetic programming effect can be carried over to postnatal mediating hyperactivation in osteoclast and reduced peak bone mass in adult offspring. This study provides an experimental basis for elucidating the mechanism of osteoclastmediated intrauterine programming of low peak bone mass in female offspring of PDE and for exploring its early targets for prevention and treatment.

11Β-Hydroxysteroid Dehydrogenase 2: A Key Mediator of High Susceptibility to Osteoporosis in Offspring after Prenatal Dexamethasone Exposure.

Positive Programming of the GC-IGF1 Axis Mediates Adult Osteoporosis Susceptibility in Male Offspring Rats Induced by Prenatal Dexamethasone Exposure.

Low-activity programming of the PDGFRβ/FAK pathway mediates H-type vessel dysplasia and high susceptibility to osteoporosis in female offspring rats after prenatal dexamethasone exposure

Prenatal dexamethasone exposure reduces osteoprogenitor proliferation in mice via histone modifications at the Mkp-1 gene locus

The Mir-98-3p/jag1/notch1 Axis Mediates the Multigenerational Inheritance of Osteopenia Caused by Maternal Dexamethasone Exposure in Female Rat Offspring

Increased H3K27ac level of ACE mediates the intergenerational effect of low peak bone mass induced by prenatal dexamethasone exposure in male offspring rats

Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mice offspring

Subchondral Bone Dysplasia Partly Participates in Prenatal Dexamethasone Induced-Osteoarthritis Susceptibility in Female Offspring Rats.

Inhibition of Mir-6215 Rescued Low Subchondral Bone Mass Caused by Maternal Exposure to Dexamethasone in Female Offspring Rats.

LOX Overexpression Programming Mediates the Osteoclast Mechanism of Low Peak Bone Mass in Female Offspring Rats Caused by Pregnant Dexamethasone Exposure

Repeated Maternal Dexamethasone Treatments in Late Gestation Increases 11Β-Hydroxysteroid Dehydrogenase Type 1 Expression in the Hippocampus of the Newborn Rat

The Low‐expression Programming of 11β‐hsd2 Mediates Osteoporosis Susceptibility Induced by Prenatal Caffeine Exposure in Male Offspring Rats

The Role of Chondrocyte-to-osteoblast Trans-Differentiation in Fetal Bone Dysplasia of Mice Caused by Prenatal Exposure to Dexamethasone

Epigenetic Programming Mediates Abnormal Gut Microbiota and Disease Susceptibility in Offspring with Prenatal Dexamethasone Exposure.

Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mouse offspring

Dexamethasone induces developmental axon damage in the offspring hippocampus by activating miR-210-3p / miR-362-5p to target the aberrant expression of Sonic Hedgehog

Epigenetic repression of AT2 receptor is involved in β cell dysfunction and glucose intolerance of adult female offspring rats exposed to dexamethasone prenatally

11β-hydroxysteroid dehydrogenases-2 decreases the apoptosis of MC3T3/MLO-Y4 cells induced by glucocorticoids

Decreased H3K9ac Level of AT2R Mediates the Developmental Origin of Glomerulosclerosis Induced by Prenatal Dexamethasone Exposure in Male Offspring Rats.

Autophagy Inhibition Mediated by Intrauterine Mir-1912-3p/ctsd Programming Participated in the Susceptibility to Osteoarthritis Induced by Prenatal Dexamethasone Exposure in Male Adult Offspring Rats.

Maternal prednisone exposure during pregnancy elevates susceptibility to osteoporosis in female offspring: The role of mitophagy/FNDC5 alteration in skeletal muscle